Wednesday, June 17, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 588
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

588 results for “placebo” Back to intelligence hub

Search results

Page 21 of 25
  1. Placebo

    BioXcel Therapeutics

    Alcohol Use Disorder (AUD)

    phase 1 small molecule completed

    1 trial
  2. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 1 small molecule completed

    1 trial
  3. Placebo

    IONIS PHARMACEUTICALS INC

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  4. Placebo

    Madrigal Pharmaceuticals EU Limited

    Drug Safety

    phase 1 small molecule completed

    2 trials
  5. Placebo

    Rhythm Pharmaceuticals Netherlands B.V.

    Obesity

    phase 1 small molecule completed

    1 trial
  6. Placebo

    Mirum Pharmaceuticals International B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  7. Placebo

    KYOWA KIRIN AUSTRALIA PTY LTD

    Healthy Volunteers Essential Hypertension

    phase 1 small molecule active

    1 trial
  8. Placebo

    IONIS PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  9. Placebo

    Takeda

    Virus, Zika

    phase 1 small molecule completed

    1 trial
  10. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    THC

    phase 1 small molecule completed

    1 trial
  11. Placebo

    Sarepta Therapeutics

    Ebola Hemorrhagic Fever

    phase 1 small molecule completed

    1 trial
  12. Placebo

    Eloxx Pharmaceuticals

    Genetic Disease

    phase 1 small molecule completed

    1 trial
  13. Placebo

    Pfizer

    Respiratory Syncytial Virus Infections

    phase 1 small molecule terminated

    1 trial
  14. Placebo

    Regeneron UK Limited

    Atopic Dermatitis

    phase 1 small molecule completed

    3 trials
  15. Placebo

    Nektar Therapeutics UK Limited

    Psoriasis

    phase 1 small molecule completed

    1 trial
  16. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 1 small molecule active

    1 trial
  17. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Addiction

    phase 1 small molecule completed

    1 trial
  18. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial
  19. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Abuse

    phase 1 small molecule completed

    1 trial
  20. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule active

    1 trial
  21. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    2 trials
  22. Placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Pain

    phase 1 small molecule completed

    1 trial
  23. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Memory

    phase 1 small molecule completed

    1 trial
  24. Placebo

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.